Search For "sglt2 inhibitors"
Kidney stone risk is lowered by a class of diabetes medications: Study
Updated : 8 months ago IST
Researchers at Mass General Brigham discovered that using sodium-glucose contratransporter 2 (SGLT2) inhibitors was associated with a decreased chance of acquiring kidney stones. Their findings were published in JAMA Internal Medicine.
Read More
Sotagliflozin provides kidney, heart-related benefits to patients
Updated : 8 months ago IST
Patients with and without diabetes can benefit from sodium-glucose cotransporter-2 (SGLT2) inhibitors, which are drugs that, among other things, reduce blood sugar levels and improve heart and kidney function.
Read More
New study challenges previous link between diabetes medication and fractur
Updated : 4 years ago IST
Washington [US], May 27 (ANI): Sodium-glucose transporter-2 (SGLT2) inhibitors, which reduce renal glucose reabsorption, may help control blood sugar and protect kidney health in patients with diabetic renal failure; however, several large clinical trials have linked these drugs to a higher
Read More
Glenmark Pharmaceuticals launches fixed-drug combination for management of
Updated : 4 years, 7 months ago IST
Mumbai (Maharashtra) [India], October 26 (ANI): Glenmark Pharmaceuticals Limited (Glenmark), a research-led global pharmaceutical company has launched a fixed drug combination for the management of type 2 diabetes.
Read More
Newer Type 2 diabetes medications have heart and kidney disease benefits,
Updated : 5 years, 8 months ago IST
Washington [US], September 28 (ANI): Two newer groups of medications prescribed primarily for Type 2 diabetes treatment (SGLT2 inhibitors and GLP-1 receptor agonists) could significantly reduce risks associated with chronic kidney disease (CKD) and heart disease.
Read More